Ads
related to: efectos secundarios de la atorvastatina- Safety
Safety Profile - Learn About
Adverse Patient Reactions
- Trial Results
See Clinical Data
and Trial
- Resources
More Information
For Your Practice
- Request Samples
Get patients started
with a 14-day sample
- Safety
Search results
Results From The WOW.Com Content Network
Atorvastatin is a statin medication used to prevent cardiovascular disease in those at high risk and to treat abnormal lipid levels. [4] For the prevention of cardiovascular disease, statins are a first-line treatment. [4]
Atorvastatin, pravastatin or fluvastatin: Negative interactions are more likely with other choices. [61] Persons taking gemfibrozil, a non-statin lipid-lowering drug Atorvastatin Combining gemfibrozil and a statin increases risk of rhabdomyolysis and subsequently kidney failure [62] [63] Persons taking the anticoagulant warfarin: Any statin
Ezetimibe/atorvastatin (trade names Liptruzet, Atozet) is a cholesterol lowering combination drug. In the United States, it was approved in May 2013, by the Food and Drug Administration for the treatment of elevated low-density lipoprotein (LDL) in patients with primary or mixed hyperlipidemia as adjunctive therapy to diet. [ 1 ]
Doctors and specialists at the Murdoch Children's Research Institute in Melbourne, Australia, are studying and reprogramming the potential of the blood to treat heart failure in children.
“I want you to write down the name of every single person you’ve had unprotected sex with.” The nurse held out a pen. She was stern and no-nonsense.
Tennessee avoided an upset and remained No. 1 in the USA TODAY Sports men's basketball poll, but the rest of the top 10 got shuffled with losses.
Amlodipine/atorvastatin, sold under the brand name Caduet among others, is a fixed-dose combination medication for the treatment of high cholesterol and high blood pressure. It contains a statin and a calcium channel blocker .
AMSTERDAM (Reuters) -The head of the chemical weapons watchdog said on Thursday he would ask Syria's new leaders to grant investigators access to the country to continue work identifying ...